A detailed history of Ubs Asset Management Americas Inc transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 170,185 shares of IART stock, worth $3.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
170,185
Previous 170,651 0.27%
Holding current value
$3.89 Million
Previous $4.97 Million 37.81%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$17.14 - $31.74 $7,987 - $14,790
-466 Reduced 0.27%
170,185 $3.09 Million
Q2 2024

Aug 13, 2024

BUY
$23.14 - $34.72 $1.24 Million - $1.85 Million
53,412 Added 45.56%
170,651 $4.97 Million
Q1 2024

May 15, 2024

SELL
$33.4 - $45.2 $8,583 - $11,616
-257 Reduced 0.22%
117,239 $4.16 Million
Q3 2023

Nov 13, 2023

BUY
$37.8 - $45.97 $50,425 - $61,323
1,334 Added 1.15%
117,496 $4.49 Million
Q1 2023

May 15, 2023

BUY
$52.61 - $60.49 $816,086 - $938,320
15,512 Added 15.41%
116,162 $6.67 Million
Q4 2022

Feb 14, 2023

BUY
$42.17 - $58.6 $368,607 - $512,222
8,741 Added 9.51%
100,650 $5.64 Million
Q3 2022

Nov 14, 2022

SELL
$42.28 - $57.17 $945,380 - $1.28 Million
-22,360 Reduced 19.57%
91,909 $3.89 Million
Q2 2022

Aug 12, 2022

BUY
$53.86 - $66.52 $104,272 - $128,782
1,936 Added 1.72%
114,269 $6.17 Million
Q1 2022

May 16, 2022

BUY
$62.86 - $69.24 $439,705 - $484,333
6,995 Added 6.64%
112,333 $7.22 Million
Q4 2021

Feb 14, 2022

SELL
$62.47 - $73.25 $185,348 - $217,332
-2,967 Reduced 2.74%
105,338 $7.06 Million
Q3 2021

Nov 15, 2021

BUY
$64.97 - $76.19 $33,134 - $38,856
510 Added 0.47%
108,305 $7.42 Million
Q2 2021

Aug 16, 2021

BUY
$66.79 - $76.63 $122,626 - $140,692
1,836 Added 1.73%
107,795 $7.36 Million
Q1 2021

May 14, 2021

SELL
$62.63 - $71.15 $691,059 - $785,069
-11,034 Reduced 9.43%
105,959 $7.32 Million
Q4 2020

Mar 01, 2021

BUY
$43.31 - $66.55 $688,455 - $1.06 Million
15,896 Added 15.72%
116,993 $7.6 Million
Q3 2020

Nov 13, 2020

BUY
$43.33 - $51.72 $238,704 - $284,925
5,509 Added 5.76%
101,097 $4.77 Million
Q2 2020

Aug 14, 2020

SELL
$41.42 - $55.57 $106,573 - $142,981
-2,573 Reduced 2.62%
95,588 $4.49 Million
Q1 2020

May 15, 2020

BUY
$36.67 - $61.04 $347,851 - $579,025
9,486 Added 10.7%
98,161 $4.38 Million
Q4 2019

Feb 14, 2020

SELL
$55.73 - $62.49 $523,193 - $586,656
-9,388 Reduced 9.57%
88,675 $5.17 Million
Q3 2019

Nov 14, 2019

BUY
$53.29 - $64.59 $617,204 - $748,081
11,582 Added 13.39%
98,063 $5.89 Million
Q2 2019

Aug 15, 2019

BUY
$46.45 - $55.85 $234,108 - $281,484
5,040 Added 6.19%
86,481 $0
Q1 2019

May 14, 2019

BUY
$42.97 - $57.33 $233,584 - $311,645
5,436 Added 7.15%
81,441 $0
Q4 2018

Feb 13, 2019

BUY
$42.62 - $64.51 $215,529 - $326,227
5,057 Added 7.13%
76,005 $3.43 Million
Q3 2018

Nov 14, 2018

BUY
$57.63 - $65.87 $212,712 - $243,126
3,691 Added 5.49%
70,948 $0
Q2 2018

Aug 14, 2018

BUY
$54.05 - $67.23 $746,484 - $928,513
13,811 Added 25.84%
67,257 $0
Q1 2018

May 14, 2018

BUY
$46.55 - $57.38 $275,436 - $339,517
5,917 Added 12.45%
53,446 $0
Q4 2017

Feb 09, 2018

BUY
$46.22 - $51.77 $126,873 - $142,108
2,745 Added 6.13%
47,529 $0
Q3 2017

Nov 13, 2017

BUY
$47.8 - $53.63 $2.14 Million - $2.4 Million
44,784
44,784 $0

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.91B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.